Electronic nose” (eNose) technology, developed at Haifa’s Technion-Israel Institute of Technology, can detect tiny molecular changes in a patient’s blood.
A simple and quick breath test using the “electronic nose” (eNose) technology developed at Haifa’s Technion-Israel Institute of Technology has proved effective in verifying the diagnosis of atherosclerosis in patients at Petah Tikva’s Rabin Medical Center-Beilinson Campus.
The artificial nose makes use of a row of sensitive, submicroscopic (nanoparticle) gold sensors that can detect tiny molecular changes in the patient’s blood. The arrays are trained to identify disease biomarkers and screen high-risk groups for specific diseases, as well as monitor treatments in people affected by that disease. It has already been successful in detecting a variety of diseases, including some types of cancer.
The study used the eNose technology, which was developed at the Technion by Prof. Hossam Haick of the Wolfson Faculty of Chemical Engineering. Its effectiveness was verified in the diagnosis of obstructive arteriosclerosis, cancer and other diseases.
Continue reading: www.jpost.com/